In contrast to other cohesin subunits, complete loss of STAG2 is tolerated due to partial 9 compensation by STAG1. STAG2 and STAG1 have redundant roles in cell division 10 (Benedetti et al., 2017; van der Lelij et al., 2017). However, cohesin-STAG1 and cohesin-11 STAG2 have non-redundant roles in facilitating 3D genome organization to delineate tissue 12 specific gene expression (Kojic et al., 2018) . 13
14
Cohesin depletion was previously shown to alter chromatin accessibility and transcription of 15 the RUNX1 and ERG genes (Mazumdar et al., 2015) , which encode transcription factors that 16 regulate haematopoietic differentiation. Here we used CRISPR-Cas9 to edit K562 17 erythroleukaemia cells to contain a patient-specific STAG2 R614* mutation (Mullenders et 18 al., 2015) and found that RUNX1 and ERG are precociously transcribed in response to 19 phorbol 12-myristate 13-acetate (PMA)-induced megakaryocytic differentiation. 20
21
We characterised two K562 edited lines with homozygous STAG2 R614* mutation (STAG2-22 null A , STAG2-null B ) ( Figure 1A and Supplementary Figures 1-2 
; Supplementary Material). 23
Both STAG2-null lines showed complete loss of STAG2 ( Figure 1B ). STAG2-null K562 cells 24 exhibited occasional adherent characteristics ( Figure 1C ) and slower cell cycle progression 25 (Supplementary Figure 3) . Array CGH showed that both STAG2-null lines had varying minor 26 gains and losses of genetic material relative to the parental line ( Supplementary Figure 4) . 27
Nevertheless, both STAG2-null transcriptomes clustered together and were distinct from the 28 parental line (Supplementary Figure 5 ). Consistent with potential compensation by STAG1, 29 both STAG2-null lines showed 1.6-fold upregulation in STAG1 (Supplementary Figure 6) . 30
Several transcription factors, kinases, chemokines, cytokines and lineage markers that were 31 lowly expressed in parental cells were significantly upregulated in one or both STAG2-null 32 clones ( Supplementary Figure 7) . Gene set enrichment analyses revealed a loss of the typical and gained a stem cell-like expression signature ( Figure 1D and Supplementary Figure 8 ). 36
These results show that STAG2 depletion leads to profound morphological and 37 transcriptional changes. 38 39 ATAC-sequencing showed that chromatin accessibility was differentially altered at ~50,000 40 sites in STAG2-null A cells ( Figure 1E ). Motif analyses of differentially accessible sites 41 identified strong enrichment for the enhancer-regulating bZIP or AP-1 factors (FRA1, FRA2, 42 JUN-AP1) at sites of increased accessibility, and for CTCF and CTCFL (BORIS) at sites of 43 decreased accessibility ( Supplementary Figure 9 ). In STAG2-null cells we observed increased 44 chromatin accessibility at super-enhancers (SEs) defined for K562, CD34+ primary cord 45 blood cells and CD14+ monocytes ( Figure 1F ). 45% genes near SEs with differential 46 accessibility also displayed altered transcript levels in STAG2-null A cells. SE-proximal genes 47 Figure 11 ). Closer visualization revealed that the prominent ATAC 54 sites in K562 are at the stem cell-associated ERG +85 kb enhancer and at RUNX1-P2 55 promoter, and both these sites showed increased accessibility in STAG2-null A ( Figure 1G ). 56
57
To determine if STAG2 mutation affects RUNX1 and ERG expression during megakaryocyte 58 differentiation, we stimulated cells with PMA and used quantitative PCR to measure changes 59 over 72 hours. Parental K562 cells showed gradual induction of RUNX1-P1 and ERG 60 transcription during stimulation ( Supplementary Figure 12 and Figure 1H ). In contrast, 61 STAG2-null cells showed a precocious spike of RUNX1 transcription 6-12 hours post-62 stimulation from its proximal P2 promoter ( Figure 1I and Supplementary Figure 12 ). A 63 similar precocious spike was observed in transcription of ERG ( Figure 1H ). By 48 hours 64 post-stimulation, RUNX1 and ERG transcription had returned to baseline in STAG2-null cells. 65
These results imply that increased chromatin accessibility at RUNX1 and ERG in STAG2-null 66 cells leads to unrestrained transcription in response to differentiation stimuli. K562 parental 67 cells upregulated GATA1 and downregulated KLF1 by 48 hours post-stimulation 68 null cells successfully downregulated KLF1, they were not able to upregulate GATA1. 70 71 BRD4 is a bromodomain-containing protein that associates with active enhancers (Bhagwat 72 et al., 2016) . Notably, BRD4 binds at the RUNX1-P2 and ERG +85 enhancer ( Figure 1G) . Figure 1J and Supplementary Figure 14A ). Following 24 hours of treatment with 85 JQ1, cell surface protein levels of KIT reduced by 2-fold in both STAG2-null clones while 86 mRNA was reduced dramatically following 6 hours of treatment ( Figure 1J and 87
Supplementary Figure 14A-B ). However, JQ1 treatment did not increase CD15 in STAG2-88 null cells ( Figure 1J and Supplementary Figure 14A ) implying that differentiation is not 89 rescued. Collectively, the data indicate that BET inhibition can limit precocious RUNX1/ERG 90 transcription and reduce leukemic stem cell-associated KIT expression in STAG2 mutant 91 cells. 92
93
Overall our results suggest that cohesin-STAG2 depletion de-constrains the chromatin around 94 RUNX1 and ERG, which causes aberrant enhancer-amplified transcription in response to 95 differentiation signals. We show that enhancer suppression using BET inhibitor, JQ1 prevents 96 aberrant RUNX1 and ERG signal-induced transcription in STAG2 mutant cells and reduces 97 leukemic stem cell characteristics of STAG2 mutants. Graphs depict average relative mRNA levels from 3 biological replicates normalized to 2 reference genes. Black asterisks denote significant difference between WT and STAG2-null lines following PMA only treatment. Green asterisks denote significant difference between PMA only and combination of PMA and JQ1 treatment within each cell type. Significance was determined by two-way Anova. (J) Relative mean fluorescence intensity (MFI) of KIT and CD15 following treatment with control DMSO or JQ1 for 24 hours. Relative MFI for each cell type and condition was determined as a ratio of MFI in stained/unstained. Graphs represent the average of 3 biological replicates. Significance was determined by two-way Anova. Black asterisks denote a significant difference between parental (WT) and STAG2null cells for the same condition. Red asterisks denote a significant difference between DMSO and JQ1 treatment within each cell type. (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
